sorbitol has been researched along with metformin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Agius, L; Arden, C; Harbottle, A; Khan, S; Lange, AJ; Mukhtar, MH; Payne, VA | 1 |
| Fukatsu, A; Sakai, S; Samukawa, Y; Sasaki, T; Seino, Y; Ubukata, M | 1 |
| Shyangdan, DS; Uthman, OA; Waugh, N | 1 |
| Abdulhasan, M; Andresen, P; Bolnick, A; Dai, J; Howard, M; Kilburn, B; Puscheck, EE; Rappolee, DA; Shamir, AM; Xie, Y | 1 |
| Chukwuma, CI; Islam, MS | 1 |
| Fushimi, N; Hachiya, H; Ito, S; Kawai, H; Kawai, M; Mori, A; Ohashi, N; Shibuya, T; Yoshida, Y | 1 |
| Fujimori, N; Horiuchi, A; Joshita, S; Kato, N; Kimura, T; Kuribayashi, N; Matsumoto, A; Sano, K; Sugiura, A; Takahashi, Y; Tanaka, E; Tanaka, N; Umemura, T; Yamazaki, T | 1 |
| Abiru, N; Chiba, K; Haraguchi, A; Horie, I; Ito, A; Kawakami, A; Kawazoe, Y; Miyamoto, J; Morimoto, S; Osaki, M; Sato, S; Shigeno, R; Tashiro, S; Yamamoto, H | 1 |
| Brindza, J; Capcarova, M; Dupak, R; Hrnkova, J; Ivanisova, E; Kalafova, A; Kovac, J; Prnova, MS; Schneidgenova, M; Simonova, N; Tokarova, K | 1 |
2 review(s) available for sorbitol and metformin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.
Topics: Bayes Theorem; Benzhydryl Compounds; Blood Pressure; Canagliflozin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Sodium-Glucose Transporter 2 Inhibitors; Sorbitol; Weight Loss | 2016 |
3 trial(s) available for sorbitol and metformin
| Article | Year |
|---|---|
Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males.
Topics: 1-Deoxynojirimycin; Adult; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Female; Humans; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Sorbitol; Sulfonylurea Compounds; Thiazolidinediones; Triazoles | 2015 |
Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective randomized controlled pilot study.
Topics: Adiposity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipid Metabolism; Lipotropic Agents; Liver; Male; Membrane Transport Modulators; Metformin; Middle Aged; Non-alcoholic Fatty Liver Disease; Organ Size; Pilot Projects; Sodium-Glucose Transporter 2; Sorbitol; Tomography, X-Ray Computed; Ultrasonography; Weight Loss | 2018 |
The effect of luseogliflozin on bone microarchitecture in older patients with type 2 diabetes: study protocol for a randomized controlled pilot trial using second-generation, high-resolution, peripheral quantitative computed tomography (HR-pQCT).
Topics: Aged; Aged, 80 and over; Bone Density; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fractures, Bone; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Pilot Projects; Randomized Controlled Trials as Topic; Risk; Sodium-Glucose Transporter 2 Inhibitors; Sorbitol; Tomography, X-Ray Computed | 2020 |
9 other study(ies) available for sorbitol and metformin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blotting, Western; Carrier Proteins; Cells, Cultured; Diuretics; Enzyme Activation; Glucokinase; Glucose; Hepatocytes; Hypoglycemic Agents; Immunohistochemistry; Male; Metformin; Multienzyme Complexes; Phosphofructokinase-2; Phosphorylation; Protein Serine-Threonine Kinases; Protein Transport; Rats; Rats, Wistar; Ribonucleotides; Sorbitol | 2008 |
Commonly used fertility drugs, a diet supplement, and stress force AMPK-dependent block of stemness and development in cultured mammalian embryos.
Topics: AMP-Activated Protein Kinases; Animals; Aspirin; Dietary Supplements; Embryo Culture Techniques; Embryo, Mammalian; Embryonic Development; Fertility Agents; Indoles; Metformin; Mice; Sorbitol; Stem Cells; Stress, Physiological | 2016 |
Sorbitol increases muscle glucose uptake ex vivo and inhibits intestinal glucose absorption ex vivo and in normal and type 2 diabetic rats.
Topics: Absorption, Physiological; Animals; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Gastric Emptying; Gastrointestinal Transit; Glucose; Hyperglycemia; Hypoglycemic Agents; In Vitro Techniques; Insulin, Short-Acting; Intestinal Absorption; Intestinal Mucosa; Jejunum; Kinetics; Male; Metformin; Muscle, Skeletal; Nutritive Sweeteners; Random Allocation; Rats, Sprague-Dawley; Sorbitol | 2017 |
Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Non-alcoholic Fatty Liver Disease; Sodium-Glucose Transporter 2 Inhibitors; Sorbitol; Sulfonylurea Compounds; Treatment Outcome | 2020 |
The consumption of sea buckthorn (Hippophae rhamnoides L.) effectively alleviates type 2 diabetes symptoms in spontaneous diabetic rats.
Topics: Animals; Antioxidants; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fruit; Hippophae; Metformin; Rats; Rats, Zucker; Rodent Diseases; Sorbitol | 2022 |